Synergistic Antibacterial Effect of Quercetin and Cefotaxime on Extended-Spectrum β-Lactamase-Producing Acinetobacter baumannii
Trends in Sciences · 01.08.2026 · 23 (12) · 14206
DOI: 10.48048/tis.2026.14206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Sciences, online erschienen am 01.08.2026. Verfasst von Intu-orn Ayamuang und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Acinetobacter baumannii (A. baumannii) is a critical multidrug-resistant pathogen designated by the WHO as a major global health threat, with rising resistance to third-generation cephalosporins and carbapenems severely restricting therapeutic options. This study explores the novel potential of combining conventional antibiotics with plant-derived compounds, focusing on quercetin (QUE), a bioactive flavonoid. We evaluated the synergistic antibacterial activity and mechanisms of cefotaxime (CTX)–QUE combinations against 3 β-lactam-resistant A. baumannii strains (DMST 43250, DMST 44689, DMST 45378). All strains exhibited high CTX resistance (MIC 1,024 µg/mL) and harbored the blaTEM gene, consistent with β-lactamase-mediated resistance. Notably, CTX–QUE demonstrated strong synergy (FICI 0.31) against strain DMST 45378, with time kill assays confirming sustained antibacterial activity (≥ 2 log10 CFU/mL reduction compared with QUE alone). Mechanistic analyses revealed significant cytoplasmic membrane disruption, leakage of intracellular DNA/RNA, and marked morphological damage. In addition, QUE inhibited biofilm formation and altered biomolecular profiles, while exhibiting appreciable cytotoxicity in human keratinocytes under in vitro conditions. Collectively, these findings highlight the novelty of employing a natural flavonoid to potentiate β-lactam activity and support the promise of plant-derived compounds as adjunctive strategies against WHO critical priority pathogens. Further studies are warranted to validate this combination before clinical application against β-lactam-resistant A. baumannii. HIGHLIGHTS Quercetin-cefotaxime shows potent synergy against β-lactam-resistant baumannii. Synergy involves disruption of the cell wall and septal formation. Synergy-driven membrane permeabilization induces DNA, RNA, and enzyme leakage. Synergy inhibits biofilm formation and could limit cefotaxime-resistant strains. Low cytotoxicity supports adjunct therapeutic potential. GRAPHICAL ABSTRACT
Zitieren
APA
Ayamuang, I., Teethaisong, Y., Watthana, S., Sirichaiwetchakoon, K., Dunkhunthod, B., Suknasang, S., Chaiseha, Y., & Eumkeb, G. (2026). Synergistic Antibacterial Effect of Quercetin and Cefotaxime on Extended-Spectrum β-Lactamase-Producing Acinetobacter baumannii. Trends in Sciences, 23(12), 14206. https://doi.org/10.48048/tis.2026.14206
Vancouver
Ayamuang I, Teethaisong Y, Watthana S, Sirichaiwetchakoon K, Dunkhunthod B, Suknasang S, et al. Synergistic Antibacterial Effect of Quercetin and Cefotaxime on Extended-Spectrum β-Lactamase-Producing Acinetobacter baumannii. Trends in Sciences. 2026;23(12):14206. doi:10.48048/tis.2026.14206
BibTeX
@article{Ayamuang2026,
author = {Ayamuang, Intu-orn and Teethaisong, Yothin and Watthana, Santi and Sirichaiwetchakoon, Kittipot and Dunkhunthod, Benjawan and Suknasang, Siriporn and Chaiseha, Yupaporn and Eumkeb, Griangsak},
title = {Synergistic Antibacterial Effect of Quercetin and Cefotaxime on Extended-Spectrum β-Lactamase-Producing Acinetobacter baumannii},
journal = {Trends in Sciences},
year = {2026},
volume = {23},
number = {12},
pages = {14206},
doi = {10.48048/tis.2026.14206}
}
EUVIMED